LAUSR

Iv an Mart ın, Eva Villam on, Rosario Abell an, Maria Jos e Calasanz, Aroa Irigoyen, Guillermo Sanz, Esperanza Such, Elvira Mora, M ıriam Guti errez, Rosa Collado, Roc ıo Garc ıa-Serra, Mı́riam Vara, Ma Laura Blanco, Itziar Oiartzabal, Sara Álvarez, Teresa Bernal, Isabel Granada, Blanca Xicoy, Andrés Jerez, Marisa Calabuig, Rosana Diez, Ángela Gil, Marı́a Dı́ez-Campelo, Carlos Solano, Mar Tormo and the Spanish Group of Myelodysplastic Syndromes (GESMD) Hematology Department, Hospital Cl ınico Universitario de Valencia, INCLIVA Research Institute, University of Valencia, Biochemistry and Molecular Pathology Department, Hospital Cl ınico Universitario de Valencia, INCLIVA Research Institute, Valencia, CIMA LAB Diagnostics, Universidad de Navarra, Pamplona, Hematology Department, Hospital Universitario y Polit ecnico La Fe, Health Research Institute Hospital La Fe, IIS La Fe, Valencia, Genetics Department, Hospital Universitario Infanta Sof ıa, Madrid, Hematology Department, Consorcio Hospital General Universitario de Valencia, Research Foundation of the General University Hospital of Valencia, Valencia, Hematology Department, Hospital Universitario de Cruces, Barakaldo, Hematology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Hematology Department, Hospital de Txagorritxu, Vitoria-Gasteiz, NIMGenetics, Gen omica y Medicina, Hematology Department, Hospital HM Sanchinarro, Madrid, Hematology Department, Hospital Universidad de Asturias, IISPA, IUOPA, Oviedo, Summary